Anavex Life Sciences Corp (AVXL)

[Investor2014]

Gerry, if you review those EMA top level stats you will see they are made up by anything from diagnostics, devices and all sorts surgery, treatments and drugs across a whole host of indications. The stats are also heavily influenced by various cancer indications that tends to have terminal outcomes without treatment, these have a more unique risk / benefit equation compared to most other indications.

So I am not referring specifically to the AD MABS, just the simple fact that a conflated top level percentage approval figure does not directly translate to the chances of approval for Anavex in AD - just as it wouldn't for other indication except perhaps often so for cancer treatments.